EXCLUSIVE: Telomir Pharma To Raise $3 Million Via Equity Financing To Fund Its Rare Disease IND
On Wednesday, Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) announced that it had secured $3 million in equity financing through a direct investment by The Bayshore Trust, the company's largest shareholder.
The transaction involved the purchase of 1 million restricted shares of the company's common stock at $3.00 per share, representing an 18% premium to Telomir's closing share price of $2.54 on the execution date.
The transaction was structured as a straight restricted common stock transaction.This transaction follows a prior $1 million equity investment at $7.00 per share made on December 9, 2024, through The Starwood Trust, an entity affiliated with the company's largest shareholder, and complements an existing $5 million non-dilutive line of credit from the same affiliated group, which remains undrawn.
Telomir Chair and CEO Erez Aminov said it had raised $4 million in equity and secured a $5 million credit line through affiliated entities.
Telomir said its priority was to submit its IND by year-end and generate early human efficacy data in the most efficient and capital-responsible way.
Telomir is advancing two highly innovative drug candidates, Telomir-1, a first-in-class age-reversal molecule targeting the root causes of cellular decline, and Telomir-Ag2, a stabilized Silver(II) compound to address the growing threat of drug-resistant infections.
Telomir-1 is an oral small molecule that addresses five fundamental biological drivers of aging and chronic disease: mitochondrial dysfunction, oxidative stress, calcium imbalance, toxic metal accumulation (iron and copper), and telomere shortening.
In preclinical models, Telomir-1 has demonstrated reversal of the biological clock, improving both lifespan and health span, improvement of mitochondrial energy production in metabolically stressed cells, reduction of oxidative stress (ROS), a key contributor to age-related damage, correction of calcium signaling pathways associated with neurodegeneration and cell death, protection against metal-induced toxicity from iron and copper and Telomere lengthening and stabilization to support cellular regeneration.
Telomir-Ag2 is a novel Silver(II) complex stabilized using Telomir's proprietary chelation platform. Silver(II) has historically shown strong antimicrobial potential but has remained clinically impractical due to its instability—until now.
Preclinical studies demonstrated that Telomir-Ag2 is active against Escherichia coli, Pseudomonas aeruginosa, Enterococcus faecalis, Staphylococcus aureus, and Methicillin- and aminoglycoside-resistant Staphylococcus aureus (MARSA).
Price Action: TELO stock closed lower by 10.4% at $2.28 on Tuesday.
Read Next:Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market.
Get the latest stock analysis from Benzinga?
This article EXCLUSIVE: Telomir Pharma To Raise $3 Million Via Equity Financing To Fund Its Rare Disease IND originally appeared on Benzinga.com
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Faraday Future Announces Inclusion in Russell 3000® and Russell Microcap® Indexes
LOS ANGELES, June 30, 2025--(BUSINESS WIRE)--Faraday Future Intelligent Electric Inc. ("Faraday Future" or "FF") (NASDAQ: FFAI), a California-based global shared intelligent electric mobility ecosystem company, today announced that it has been added to both the Russell 3000® Index and the Russell Microcap® Index, effective at the open of the U.S. equity markets on June 30, 2025, as part of the 2025 annual Russell indexes reconstitution. Membership in the Russell 3000® Index, which remains in place for one year, means Faraday Future is also eligible for inclusion in either the Russell 1000® Index or Russell 2000® Index, and in this case additionally included in the Russell Microcap® Index, reflecting the Company's market capitalization positioning. These widely followed benchmarks are used by investment managers and institutional investors for index funds and as performance benchmarks, and inclusion can potentially increase investor awareness and broaden the shareholder base. "We are honored to be included in both the Russell 3000 and Russell Microcap Indexes," said Jerry Wang, Global President of Faraday Future. "This inclusion highlights the momentum we are building in the intelligent electric vehicle sector and underscores our commitment to delivering innovative mobility solutions that redefine premium while affordable user experiences via Faraday Future and Faraday X - our unique dual branding strategy." The annual reconstitution of the Russell US indexes captures the 4,000 largest US stocks as of April 30, ranking them by total market capitalization. Membership in the Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000® Index as well as the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Approximately $18.1 trillion in assets are benchmarked against the Russell US indexes, which belong to FTSE Russell, the global index provider. About FTSE Russell, an LSEG Business FTSE Russell is a global index leader that provides innovative benchmarking, analytics and data solutions for investors worldwide. FTSE Russell calculates thousands of indexes that measure and benchmark markets and asset classes in more than 70 countries, covering 98% of the investable market globally. FTSE Russell index expertise and products are used extensively by institutional and retail investors globally. Approximately $18.1 trillion is benchmarked to FTSE Russell indexes. Leading asset owners, asset managers, ETF providers and investment banks choose FTSE Russell indexes to benchmark their investment performance and create ETFs, structured products and index-based derivatives. A core set of universal principles guides FTSE Russell index design and management: a transparent rules-based methodology is informed by independent committees of leading market participants. FTSE Russell is focused on applying the highest industry standards in index design and governance and embraces the IOSCO Principles. FTSE Russell is also focused on index innovation and customer partnerships as it seeks to enhance the breadth, depth and reach of its offering. FTSE Russell is wholly owned by London Stock Exchange Group. For more information, visit FTSE Russell at: ABOUT FARADAY FUTURE Faraday Future is a California-based global shared intelligent electric mobility ecosystem company. Founded in 2014, the Company's mission is to disrupt the automotive industry by creating a user-centric, technology-first, and smart driving experience. Faraday Future's flagship model, the FF91, exemplifies its vision for luxury, innovation, and performance. The new FX strategy aims to introduce mass production models equipped with state-of-the-art luxury technology similar to the FF 91, targeting a broader market with middle-to-low price range offerings. FF is committed to redefining mobility through AI innovation. Join us in shaping the future of intelligent transportation. For more information, please visit View source version on Contacts Investors (English): ir@ Investors (Chinese): cn-ir@ Media:
Yahoo
an hour ago
- Yahoo
Stock market today: Dow, S&P 500, Nasdaq futures hold steady after markets close at new highs
US stock futures held steady as investors weighed improved market sentiment following fresh record highs. Futures attached to the Dow Jones Industrial Average (YM=F), the benchmark S&P 500 (ES=F), and the tech-heavy Nasdaq 100 (NQ=F) slipped 0.1%. On Monday, stocks continued a rally that started last week, with the Nasdaq and S&P 500 notching new record highs. Reports of progress on US trade deals with Canada and the European Union boosted Wall Street's mood even as the July 9 deadline for the resumption of President Trump's "reciprocal" tariffs looms. Read more: The latest on Trump's tariffs Meanwhile, the Senate is making a final push to advance Trump's signature legislation. A final vote could come as soon as Tuesday even as last-minute changes have pushed the bill's price tag up by nearly $1 trillion. With markets increasingly optimistic that an interest rate cut from the Federal Reserve could be around the corner, Thursday's job report is in high focus this week. Investors will be watching for signs of cooling in the labor market, which could bolster the case for a cut sooner rather than later. Trading will end early on Thursday at 1 p.m. ET due to the Fourth of July holiday.
Business Wire
2 hours ago
- Business Wire
Accelerant Holdings Announces Public Filing of Registration Statement for Initial Public Offering
ATLANTA--(BUSINESS WIRE)--Accelerant Holdings ('Accelerant') announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission ('SEC') relating to a proposed underwritten initial public offering of its Class A common shares. The timing of the offering, number of Class A common shares to be offered and the price range for the proposed offering have not yet been determined. The Class A common shares to be offered and sold in the proposed offering are expected to be offered by Accelerant and certain selling shareholders. The initial public offering is subject to market and other conditions. Accelerant intends to list its Class A common shares on the New York Stock Exchange under the ticker symbol 'ARX.' Morgan Stanley & Co. LLC is acting as lead left active bookrunner, Goldman Sachs & Co. LLC is acting as lead right active bookrunner, and BMO Capital Markets Corp. and RBC Capital Markets, LLC are acting as active bookrunners for the proposed offering. The proposed offering will be made only by means of a prospectus. When available, copies of the preliminary prospectus relating to the proposed offering may be obtained from Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014 or by email at prospectus@ Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, NY 10282, by telephone at (866) 471-2526, or by email at prospectus-ny@ BMO Capital Markets Corp., Attention: Equity Syndicate Department, 151 W 42nd Street, 32nd Floor, New York, NY 10036, by telephone at (800) 414-3627, or by email at bmoprospectus@ RBC Capital Markets, LLC, Attention: Equity Capital Markets, 200 Vesey Street, 8th Floor, New York, NY 10281, by telephone at (877) 822-4089, or by email at equityprospectus@ A registration statement relating to the Class A common shares has been filed with the SEC but has not yet become effective. The Class A common shares may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities, and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction. ABOUT ACCELERANT Accelerant is a data-driven risk exchange connecting underwriters of specialty insurance risk with risk capital providers. Accelerant was founded in 2018 by a group of longtime insurance industry executives and technology experts who shared a vision of rebuilding the way risk is exchanged – so that it works better, for everyone. The Accelerant risk exchange does business across 22 different countries and more than 500 specialty insurance products.
